المؤلفون: Debaudringhien, M., Blay, Jean-Yves, Bimbai, André-Michel, Bonvalot, Sylvie, Italiano, Antoine, Rousset-Jablonski, Christine, Corradini, Nadège, Piperno-Neumann, Sophie, Chevreau, Christine, Kurtz, Jean-Emmanuel, Guillemet, Cécile, Bompas, Emmanuelle, Collard, Olivier, Salas, Sebastien, Le Cesne, Axel, Orbach, Daniel, Thery, Julien, Le Deley, Marie-Cécile, Mir, Olivier, Penel, Nicolas

المساهمون: Université de Lille, CHU Lille, Centre Léon Bérard Lyon, Centre Régional de Lutte contre le Cancer Oscar Lambret Lille UNICANCER/Lille, Institut Curie Paris, Institut Bergonié Bordeaux, Centre Hospitalier Lyon Sud CHU - HCL CHLS, Institut Claudius Regaud, Centre Hospitalier Universitaire Strasbourg CHU Strasbourg, Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen CLCC Henri Becquerel, Institut de Cancérologie de l'Ouest Angers/Nantes UNICANCER/ICO, Institut de Cancérologie de la Loire Lucien Neuwirth, Hôpital de la Timone CHU - APHM TIMONE, Institut Gustave Roussy IGR, Centre de recherche en épidémiologie et santé des populations CESP, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

مصطلحات موضوعية: desmoid-type fibromatosis, hormonal contraception, hormone-dependency tumor, outcome, pregnancy

وصف الملف: application/rdf+xml; charset=utf-8; application/pdf

Relation: European Society for Medical Oncology; ESMO Open; http://hdl.handle.net/20.500.12210/89986

الاتاحة: https://hdl.handle.net/20.500.12210/89986

المؤلفون: Debaudringhien, M., Blay, Jean-Yves, Bimbai, André-Michel, Bonvalot, Sylvie, Italiano, Antoine, Rousset-Jablonski, Christine, Corradini, Nadège, Piperno-Neumann, Sophie, Chevreau, Christine, Kurtz, Jean-Emmanuel, Guillemet, Cécile, Bompas, Emmanuelle, Collard, Olivier, Salas, Sébastien, Le Cesne, Axel, Orbach, Daniel H., Thery, Julien, Le Deley, Marie Cécile, Mir, Olivier, Penel, Nicolas

المساهمون: Université de Lille, Centre Léon Bérard Lyon, Centre Régional de Lutte contre le Cancer Oscar Lambret Lille (UNICANCER/Lille), Université de Lille-UNICANCER, Institut Curie Paris, Institut Bergonié Bordeaux, UNICANCER, Institut Claudius Regaud, Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg), Les Hôpitaux Universitaires de Strasbourg (HUS), Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Institut de Cancérologie de l'Ouest Angers/Nantes (UNICANCER/ICO), Institut de Cancérologie de la Loire Lucien Neuwirth, Centre Hospitalier Universitaire de Saint-Etienne CHU Saint-Etienne (CHU ST-E), Hôpital de la Timone CHU - APHM (TIMONE), Institut Gustave Roussy (IGR), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Institut National de la Santé et de la Recherche Médicale, Inserm, Ligue Contre le Cancer: PRE2016.LCC/NP, Companhia Energética de São Paulo, CESP, Institut National Du Cancer, INCa, The authors would like to thank the patients and families for their participation in this study, the staff members involved in study management, in particular Emilie Decoupigny and Marie Vanseymortier from the sponsorship unit at Centre Oscar Lambret (Lille University), all investigators and their teams who participated in the study, the patient advocacy group ‘SOS Desmoïde’, Guillemette Antoni, a biostatistician from CESP (INSERM Villejuif), for her advice, Françoise Bonichon for her help in the literature research, and the data-managers from Centre de Traitement des Données du Cancéropôle Nord-Ouest (CTD-CNO), who oversaw the study data management, the CTD-CNO clinical research platform was funded by the French National Cancer Institute (INCa) and ‘La Ligue Nationale Contre le Cancer’., This work was supported by a personal grant from a donor (S. Wisnia), the Ligue Nationale Contre le Cancer (PRE2016.LCC/NP), Intersarc (funded by the French National Cancer Institute , INCA ), and SOS Desmoïde (no grant number). These funders had no role in the design, conduct, or reporting of this work.

المصدر: ISSN: 2059-7029 ; ESMO Open ; https://hal.science/hal-03837188 ; ESMO Open, 2022, 7 (5), pp.100578. ⟨10.1016/j.esmoop.2022.100578⟩.

مصطلحات موضوعية: desmoid-type fibromatosis, hormonal contraception, hormone-dependency tumor, outcome, pregnancy, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/36116422; hal-03837188; https://hal.science/hal-03837188; https://hal.science/hal-03837188/document; https://hal.science/hal-03837188/file/PIIS2059702922002083.pdf; PUBMED: 36116422; PUBMEDCENTRAL: PMC9588892

الاتاحة: https://hal.science/hal-03837188
https://hal.science/hal-03837188/document
https://hal.science/hal-03837188/file/PIIS2059702922002083.pdf
https://doi.org/10.1016/j.esmoop.2022.100578

المؤلفون: Debaudringhien, M., Blay, J-Y., Bimbai, A.M., Bonvalot, S., Italiano, A., Rousset-Jablonski, C., Corradini, N., Piperno-Neumann, S., Chevreau, C.M., Kurtz, J.E., Guillemet, C., Bompas, E., Collard, O., Salas, S., Le Cesne, A., Orbach, D., Thery, J., Deley, M-C. Le, Mir, O., Penel, N.

المصدر: Annals of Oncology ; volume 32, page S1112 ; ISSN 0923-7534

الاتاحة: http://dx.doi.org/10.1016/j.annonc.2021.08.852
https://api.elsevier.com/content/article/PII:S0923753421030817?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753421030817?httpAccept=text/plain